Science study unveils Virtual Biotech, a multi-agent AI system for drug development decisions
james_y_zou · x · 2026-09-23
A new study in Science presents Virtual Biotech, a multi-agent AI system designed to inform drug-development decisions. By combining diverse biomedical and clinical evidence on a unified platform, the system can surface therapeutic opportunities that would otherwise be missed — a notable example of AI agents operating in a high-stakes biomedical research domain.
More from Research
- TensorSharp's logit-reading approach beats LocalJev at structured decisions, 3.3x faster — fuzhongkai · 2026-09-23
- Naproche: a proof assistant that reads math proofs written in controlled natural language — zetalyrae · 2026-09-23
- Nanjing University used AI to design proteins 4x stronger than any natural protein — MikePFrank · 2026-09-23
- Open-source GUI agents top out at 8% task success on composite cross-device tasks — maier_ak · 2026-09-23
- JarvisGUI benchmark tests GUI agents across Android, Windows and Ubuntu in one workflow — maier_ak · 2026-09-23
- Cross-DURIAN: A New Benchmark for Multi-Device GUI Agents — maier_ak · 2026-09-23